Allan Detsky's timely editorial1 invites us to take a broader look at the biases that shape the
recommendations in clinical practice guidelines, beyond financial links with the …

In his letter to CMAJ, Mr. Ross has engaged in selective citation to support his position that
opioids are highly effective for chronic noncancer pain and that development of opioid use …

We value Drs. Weinberg's and Baer's careful review and feedback1 on the 2017 Canadian
Guideline for Opioid Therapy and Chronic Noncancer Pain, 2 and we would like to respond …

Background Starting in the late 1990s, the pharmaceutical industry sought to increase
prescribing of opioids for chronic non-cancer pain. Influencing the content of clinical practice …

Clinical Practice Guidelines Grade Tables Page 1 G-1 Grading of Recommendations
Assessment, Development and Evaluation (GRADE) clinical evidence review ratings of the …

The qualitative study by Langford and colleagues,“The lesser of 2 evils”: a framework
analysis of consumers' perspectives on opioid deprescribing and the development of opioid …

There is a new front in the ongoing battle to preserve access to pain relief, and a Trojan
horse is nestled inside a measure intended to protect patients from harm. It takes the form of …

Transparency, freedom from bias, and accountability are, in principle, hallmarks of taxpayer-
funded institutions. Unfortunately, it seems that at least one institution, the Centers for …

ABSTRACT On February 10, 2022, the US Centers For Disease Control and Prevention
(National Center for Injury Prevention and Control) circulated a draft revised and expanded …

Vowles et al. 6 provide definitions for misuse, abuse, and addiction, which deviate from what
is generally understood by these terms. This creates confusion and is a potential source for …